Thromb Haemost 1993; 69(04): 403
DOI: 10.1055/s-0038-1651623
Letter to the Editor
Schattauer GmbH Stuttgart

Factor VIII Inhibitor Associated with Ciprofloxacin

Edwin J R van Beek
Centre for Hemostasis, Thrombosis, Atherosclerosis and Inflammation Research, Academic Medical Centre, University of Amsterdam, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands
,
Marjolein Peters
Centre for Hemostasis, Thrombosis, Atherosclerosis and Inflammation Research, Academic Medical Centre, University of Amsterdam, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands
,
Jan W ten Cate
Centre for Hemostasis, Thrombosis, Atherosclerosis and Inflammation Research, Academic Medical Centre, University of Amsterdam, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands
› Author Affiliations
Further Information

Publication History

Received 15 July 1992

Accepted after revision 01 December 1992

Publication Date:
05 July 2018 (online)

 
  • References

  • 1 Ehrenforth S, Kreuz W, Scharrer I. et al Incidence of development of factor VIII and factor IX inhibitors in haemophiliacs. Lancet 1992; 339: 594-598
  • 2 Choe U, Rothschild BM, Laitman L. Ciprofloxacin-induced vasculitis. N Engl J Med 1989; 320: 257-258
  • 3 Stubbings J, Sheehan-Dare R. Walton S. Cutaneous vasculitis due to ciprofloxacin. Br Med J 1992; 305: 29
  • 4 Peters B, Pinching AJ. Fatal anaphylaxis associated with ciprofloxacin in a patient with AIDS related complex. Br Med J 1989; 298: 605
  • 5 Wurtz RM, Abrams D, Becker S, Jacobson MA, Mass MM, Marks SH. Anaphylactoid drug reactions to ciprofloxacin and rifampicin in HIV-infected patients. Lancet 1989; i: 955-956
  • 6 Rodriguez E, Martinez JA, Torres M, Nubiola A, Buges J. Lobular panniculitis associated with ciprofloxacin. Br Med J 1990; 300: 1468
  • 7 Mumford CJ, Ginsberg J. Ciprofloxacin and myasthenia gravis. Br Med J 1990; 301: 818